AMILI

ActiveOn the Singapore Radar · not ranked

Microbiome · Singapore

Gut-microbiome company running a stool bank and sequencing platform for Asian populations, offering microbiome tests, transplants and data for research and personalised nutrition.

Biotech›microbiome amili.asia

Last roundSeries A · Jun 2022

Why AMILI is not ranked yet

How the Radar works →

The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. AMILI enters the ranking once its public data is sufficient for the AI to estimate it. Next Singapore edition: 2 Nov 2026.

Funding history

Date	Round	Amount	Type	Investors
Jun 2022	Series A	USD 10M	—	Vulcan Capital, Pruksa Group, TVM Capital Healthcare, Emtek Group

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Singapore · all sectors	Radar	—	Edition 0 · October 2026	2 Nov 2026

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of AMILI as a PDF. It must answer at least one of these four questions, and stick to them:

ValuationWhat is AMILI worth?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back AMILI whether or not it has agreed: your intention joins the pool on AMILI, passed to the Fundraising Desk of its country once it reaches critical mass. Backing on Uback (pronounced “you back”) means declaring an Interest (free) or an Intention (coming soon). Backing does not mean that this company is raising funds or that a shareholder is selling shares, and it is not a commitment to invest. Any deal, through a funding round or a sale by an existing shareholder, is handled by a partner desk: the Fundraising Desk of the country for a round, the Secondary Sales Desk assigned to the company for a sale.

Back AMILI Or back biotech in Singapore

Pool on AMILIBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until you sign with a partner desk. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run AMILI?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in Singapore

Full Singapore ranking →

Hummingbird Bioscience#12Biotech › antibody therapeuticsHundreds of M$Nuevocor#30Biotech › gene therapyHundreds of M$Engine Biosciences#39Biotech › AI drug discoveryHundreds of M$Allozymes#46Biotech › enzyme engineeringTens of M$

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.